| Application no. and date | 09756528.7 (espacenet) (Federated) (European Patent Register), 20091125 | | Patent/reg. no. and date | DK/EP 2370076, 20170104 | | Publication date | 20111005 | | Priority no. and date | EP 08170279, 20081128, EP 08170246, 20081128, EP 08170230, 20081128, EP 08170287, 20081128 | | EP pub. no. and date |
EP 2370076 20111005 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/154791 | | Inventor | JENSEN, Michael, Rugaard, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
GARCIA-ECHEVERRIA, Carlos, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61K 31/5377 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutisk kombination omfattende en Hsp 90-inhibitor og en mTOR-inhibitor | | Int. application no. | EP2009065858 | | Int. publication no. | WO2010060937 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
